Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-214860.98%
operating margin TTM
-230460.98%
revenue TTM
643.32 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -3.30 |
| peg ratio | -0.11 |
| price to book ratio | 1.29 |
| price to sales ratio | 6,221.06 |
| enterprise value multiple | -2.94 |
| price fair value | 1.29 |
profitability ratios | |
|---|---|
| gross profit margin | -36387.8% |
| operating profit margin | -230460.98% |
| pretax profit margin | -216521.95% |
| net profit margin | -214860.98% |
| return on assets | -31.47% |
| return on equity | -49.35% |
| return on capital employed | -35.67% |
liquidity ratios | |
|---|---|
| current ratio | 18.55 |
| quick ratio | 18.55 |
| cash ratio | 2.92 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 10,852.07 |
| days of payables outstanding | 66.29 |
| cash conversion cycle | 10,785.78 |
| receivables turnover | 0.03 |
| payables turnover | 5.51 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.13 |
| debt equity ratio | 0.16 |
| long term debt to capitalization | 0.13 |
| total debt to capitalization | 0.14 |
| interest coverage | -57.76 |
| cash flow to debt ratio | -1.90 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.67 |
| cash per share | 2.72 |
| operating cash flow per share | -0.67 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.90 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -6,166.64 |
Frequently Asked Questions
When was the last time Altimmune, Inc. (NASDAQ:ALT) reported earnings?
Altimmune, Inc. (ALT) published its most recent earnings results on 06-11-2025.
What is Altimmune, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Altimmune, Inc. (NASDAQ:ALT)'s trailing twelve months ROE is -49.35%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Altimmune, Inc. (ALT) currently has a ROA of -31.47%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ALT's net profit margin stand at?
ALT reported a profit margin of -214860.98% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ALT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 18.55 in the most recent quarter. The quick ratio stood at 18.55, with a Debt/Eq ratio of 0.16.